The gene encodes an ion transporter regulator, whose mutations cause hypomagnesaemia with hypocalciuria.
Epidemiological data concerning this disease are very restricted.
The gene is about 9,2 kb in size. Alternatively the gene is named sodium-potassium ATPase gamma-1 polypeptide (ATP1G1). It is located on chromosome 11 at position 11q23. It consists 7 exons. Two different isotypes using different promotors are described.
Only one loss-of-function mutation is known so far. In this family also a hypocalciuria occurred. The mode of inheritance was autosomal dominant.
The gene is transcribed in pancreas in kidney. In the latter, it is found in the distal convolution. The different isotypes of the protein contain 58 or 66 amino acids. The gene forms a transmembraneous domain and functions as a regulating component of the sodium-potassium ATPase.
Family counseling is the only therapeutical consequence at the moment.
Clinic | Method | Carrier testing |
Turnaround | 5 days | |
Specimen type | genomic DNA |
Clinic | Method | Massive parallel sequencing |
Turnaround | 25 days | |
Specimen type | genomic DNA |
Clinic | Method | Genomic sequencing of the entire coding region |
Turnaround | 10 days | |
Specimen type | genomic DNA |
1. |
Meij IC et al. (2000) Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. |
2. |
Kantorovich V et al. (2002) Genetic heterogeneity in familial renal magnesium wasting. |
3. |
Orphanet article Orphanet ID 121972 |
4. |
NCBI article NCBI 486 |
5. |
OMIM.ORG article Omim 601814 |
6. |
Wikipedia article Wikipedia EN (FXYD2) |